Kiromic Book Value per Share from 2010 to 2024

KRBPDelisted Stock  USD 1.45  0.00  0.00%   
Check Kiromic BiopharmaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiromic main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Kiromic financial statements analysis is a perfect complement when working with Kiromic BiopharmaInc Valuation or Volatility modules.
  
This module can also supplement various Kiromic BiopharmaInc Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About Kiromic BiopharmaInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Kiromic BiopharmaInc income statement, its balance sheet, and the statement of cash flows. Kiromic BiopharmaInc investors use historical funamental indicators, such as Kiromic BiopharmaInc's Book Value per Share, to determine how well the company is positioned to perform in the future. Although Kiromic BiopharmaInc investors may use each financial statement separately, they are all related. The changes in Kiromic BiopharmaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kiromic BiopharmaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kiromic BiopharmaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kiromic BiopharmaInc. Please read more on our technical analysis and fundamental analysis pages.
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Kiromic Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Kiromic BiopharmaInc information on this page should be used as a complementary analysis to other Kiromic BiopharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Kiromic Stock

If you are still planning to invest in Kiromic BiopharmaInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic BiopharmaInc's history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account